DIABETES MELLITUS IN COVID-19 PATIENTS: VERDICT OR NOT?

ABSTRACT

OBJECTIVE: The aim: To investigate the causes of the negative impact of diabetes mellitus co-morbidity on the onset and development of COVID-19 in diabetic patients. PATIENTS AND METHODS: Materials and methods: Electronic databases of MEDLINE and Google Scholar were searched using keyword searches. CONCLUSION: Conclusions: 1. Diabetes mellitus is not a verdict. Diabetic patients can have COVID-19 with the same frequency as other people. And diabetes mellitus co-morbidity does not increase the probability of development COVID-19. 2. Previous diabetes can contribute the complications of COVID-19, patient's severe condition and can increase the mortality. 3. The reasons for the negative results of COVID 19 treatment in patients with diabetes may be features of autonomic innervation in patients with diabetes, impaired function of pancreatic islet cells due to the influence of SARS-CoV-2, use of some cardiac drugs, expression of inflammatory factors due to infection.